Compuen (CGEN) Nyalo Cwiny me Stock
AI forecast: CGEN
AI otyeko kwena ya ceng ma lwenyo, gima agik juma, ki gima agik juma. Kwena en gima iyar ki neno kwena ma nyaka. Gin en neno ki kare, onyo nyutu ya yat.
Jaji e lweny e dwe 6 mag giko
Premium nyalo neno ceng'a AI me yweyo piyo ki 1 odiiyo, 1 juma ki 1 dwe ki gima onongo ki gikato ma okato.
Unlock Premium🔒 Nyinge yoo oryeto
Neno kare duto — forecast duto ma otyeko ki kwena ma otyeko — en pake Premium.
Unlock PremiumNyinge Aciya Man
Compugen Ltd. is engaged in the research, development, and distribution of targeted and therapeutic drugs. The company’s portfolio primarily consists of early-stage and preclinical immuno-oncology programs aimed at developing cancer immunotherapies, both as monotherapies and in combination with other drugs. The company is also developing treatments for autoimmune diseases.